Markus Lenzhofer

9PUBLICATIONS
3CO-AUTHORS
Nanotoxicology, health and safetyOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)Compound semiconductorsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 08, 2026
The efficacy and safety of the XEN63 glaucoma gel stent without Mitomycin C over the first 10 years.

|Mar 13, 2024
Mid-term surgical success after transscleral ab interno glaucoma gel stent implantation.

Markus Lenzhofer, Melchior Hohensinn, Veit Steiner

|Nov 26, 2022
Five-year follow-up of corneal endothelial cell density after transscleral ab interno glaucoma gel stent implantation.

Markus Lenzhofer, Armin Motaabbed, Hans Peter Colvin

|May 11, 2021
Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study.

Herbert Reitsamer, Vanessa Vera, Simon Ruben

|Apr 02, 2021
Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation.

Markus Lenzhofer, Melchior Hohensinn, Wolfgang Hitzl

|Sep 09, 2019
Change in visual acuity 12 and 24 months after transscleral ab interno glaucoma gel stent implantation with adjunctive Mitomycin C.

Markus Lenzhofer, Clemens Strohmaier, Melchior Hohensinn

Pageof 2

Frequent Collaborators

2 joint publications

Herbert Reitsamer

1 joint publications

Vanessa Vera

1 joint publications

Ingeborg Stalmans